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Abstract
We report on a 14 year old boy who presented with the symptoms abdominal pain, fever and
proteinuria. A hematoma in the region of the right pararenal space was diagnosed. Prothrombin
time and activated partial thromboplastin time were prolonged, lupus anticoagulant and
anticardiolipin antibodies were positive and serum cortisol was normal. Ten days after admission
the boy suddenly suffered generalized seizures due to low serum sodium. As well, the patient
developed hemolytic anemia, acute elevated liver enzymes, hematuria and increased proteinuria.
At this time a second hemorrhage of the left adrenal gland was documented. Adrenal function tests
revealed adrenal insufficiency. We suspected microthromboses in the adrenals and secondary
bleeding and treated the boy with hydrocortisone, fludrocortisone and phenprocoumon.
Conclusion: Adrenal failure is a rare complication of APS in children with only five cases reported
to date. As shown in our patient, this syndrome can manifest in a diverse set of simultaneously
occurring symptoms.
Background
The antiphospholipid syndrome is characterized by clini-
cal evidence of arterial or venous thrombosis and repeated
presence of antiphospholipid autoantibodies. The dis-
ease, first described by Hughes in 1983 [1], may occur in
a variety of conditions including neoplasms, infections,
other autoimmune disease such as lupus erythematodes,
and after administration of certain drugs. If found without
any other demonstrable disease, it is termed primary
antiphospholipid syndrome.
The autoantibodies, of which the most important are
lupus anticoagulant and cardiolipin-antibodies, comprise
a heterogeneous group which are mainly directed against
complexes of anionic phospholipid with some phosphol-
ipid-binding proteins such as beta-2-glycoprotein I and
human prothrombin. In a proportion of individuals the
circulation of the antibodies may induce thrombosis of
virtually any vein or artery. The most common are deep
vein thrombosis, pulmonary, or cerebrovascular embo-
lisms. In addition, other complications such as cardiomy-
opathy, hepatitis, hemolytic anemia, bleeding, vasculitis
and renal failure have been reported [2-5].
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complications, led us to conclude that this syndrome is an
important differential diagnosis in patients with the
described symptoms.
Case Report
In September 2001, a previously healthy, Caucasian, 14-
year-old boy was admitted to our hospital. Two weeks
prior to his arrival, he had developed abdominal pain, a
recurring fever of up to 39°C, and an intermittent cough.
These symptoms were worsening and his general condi-
tion was deteriorating.
On examination he had diffuse abdominal pain located
primarily in the upper abdomen, and his temperature was
38.5°C. His skin and the further physical examination
was normal. Pertinent laboratory investigations are listed
in Table 1. Of note, the activated partial thromboplastin
time and prothrombin time were both prolonged, mild
thrombopenia and leukocytosis of 14/nl were present,
and C-reactive protein was elevated (6.1 mg/dl). The
activity of factors II, V, VII and VIII was normal. There was
no history of autoimmune diseases or coagulation disor-
ders in his family.
The initial abdominal ultrasound revealed a tumor in the
right pararenal space. However, a clear anatomical rela-
tion to the adrenal gland could not be established (Figures
1 and 2- see Additional file 1 and 2). The left adrenal
gland was slightly enlarged. Doppler ultrasonography
showed no thromboses of abdominal vessels and serum
cortisol was normal at this stage. The CT scan identified
the tumor as hematoma.
Additional tests were positive for lupus anticoagulant and
anti-cardiolipin antibodies. Bleeding time was prolonged
to 11 minutes but all other coagulation tests eliminated
the possibility of acute bleeding. In fact a repeated test of
bleeding time a few days later was normal.
Under intravenous treatment with cefuroxim the patient's
temperature normalized within two days. But by day five,
C-reactive protein increased to 12 mg/dl, and the patient's
temperature rose again so antibiotic therapy was extended
by gentamycin.
Ten day after being admitted, the boy suddenly suffered
generalized tonic-clonic seizures due to severe
hyponatremia of 111 mmol/l. Serum transaminases
Table 1: Expression of important laboratory findings
Variable Day 1 Day 5 Day 10 Day 15 Day 25 Day 50 12 month Normal range
IgG anti-cardiolipin antibody (GPL-U/ml) 44.7 21 60.2 30.7 37.7 <12
Lupus anticoagulant positive positive positive positive positive absent
Anti-β-2-Glycoprotein 1 (U/ml) 2 6 3 negative <5
Anti-Phosphatidylserin (U/ml) 72.8 10.8 31.1 <15
Anti-Phosphatidylethanolamin (U/ml) 45.2 23.9 18.5 <15
Antinuclear antibodies negative negative absent
ENA negative absent
Double strand-DNA negative absent
anti-adrenal-antibodies negative absent
Cortisol 0800 h 26 1.1 22 28 6–26
Renin activity 100 <3β
ACTH (pg/ml) 468 <50
Aldosteron (pg/l) <10 12–125
DHEA-sulfate (g/dl) <10 <280
Bleeding time (min) 10.55 5.30 <7
Partial thromboplastin time (s) 39 37 48 57 58 36 41 <35
Prothrombin time (%) 64 55 55 73 78 45 36 70–100
Sodium (mmol/l) 134 140 111 139 142 143 136 132–145
Potassium (mmol/l) 3.9 4.8 3.6 4.2 4.0 3.5 3.9 3.1–5.1
C-reactive Protein (mg/dl) 6.1 6.1 12.1 3.7 1.0 0.4 0.3 <0.5
Aspartate aminotransferase (U/l) 15 17 81 37 21 16 18 <15
Alanine aminotransferase (U/l) 20 18 67 69 40 24 22 <14
LDH (U/l) 201 442 309 256 181 <240
Creatinine (mg/dl) 0.7 0.7 1.0 0.7 0.8 0.93 0.3 0.6–1.3
β2-microglobulin (mg/dl) 0.18 0.27 0.19 <0.08
Hemoglobin (g/l) 13.6 11.1 7.6 10.8 11.8 12.1 12.4 11.8–16.8
Platelet count /nl 129 177 56 154 97 153 174 150–350
White cell count /nl 14.5 10.3 10.2 6.2 5.4 5.6 7.8 4.3–10.0Page 2 of 4
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three days hemoglobin dropped from 11.8 g/l to 7.6 g/l.
Since LDH was elevated and haptoglobin was reduced, we
diagnosed hemolytic anemia and transfused him with
erythrocyte concentrates.
Two days before the acute onset of adrenal insufficiency,
microhematuria began. Proteinuria increased to 1 g/l and
β-2-microglobulin raised to 0.16 mg/dl but there were no
clinical signs of urinary infection. As the C-reactive pro-
tein rose to 16.1 mg/dl, intravenous antibiotic treatment
was changed to erythromycin, ceftriaxon, tobramycin and
flucloxacillin. However, two blood cultures, urine culture,
stool culture and liquor culture remained sterile. Further-
more, serum serological tests were negative for the follow-
ing infections: borrelia-burgdorferi, HIV, hepatitis B virus,
hepatitis C virus, listeria, leptospira, epstein-barr-virus,
treponema pallidum, parvovirus B 19, cytomegalie virus,
mycoplasma pneumonia, coxsackivirus type B1-B6,
chlamydia pneumonia and toxoplasmosis. Tuberculosis
was ruled out by mendel-mantoux skin test, microscopy
of Ziehl-Nelson stained urine samples, PCR of a urine and
liquor sample, and chest x-ray.
The boy was transferred to the intensive care unit and
hyponatremia was balanced within the next 12 h with
intravenous application of NaCl 5.85%. Over the course
of the next 5 h until his serum sodium was above 125
mmol/l, he had repeated convulsions for up to 30 min-
utes. Due to status epilepticus and marked agitation, intu-
bation and artificial ventilation was required.
A second CT scan on the next day showed a novel hemor-
rhage of the left adrenal as well and bleeding in the right
pararenal region had enlarged (Figure 3- see Additional
file 3). A CT scan of the head was normal, cortisol was low
and the adrenals were unresponsive to the Synacten test.
We started treatment with hydrocortisone, fludrocorti-
sone and 10 days later with phenprocoumon.
Under this treatment the boy improved clinically within
two days and was extubated. As well, laboratory signs of
hepatitis normalized within the next three weeks and
hemoglobin remained in normal range after blood trans-
fusion. The C-reactive protein normalized within 10 days
and antibiotic treatment was stopped as no other clinical
or laboratory signs of infection were present.
We continued to monitor the patients condition. As
shown in table 1, lupus anticoagulant and cardiolipin
antibodies remained positive. He did not develop any
other autoimmune diseases (Table 1). The boy's parents
and his brother were negative for lupus anticoagulant and
cardiolipin antibodies.
Discussion
The antiphospholipid syndrome is a rare disease in child-
hood, significantly related to thrombotic events. How-
ever, in our patient, initial acute intraabdominal
hemorrhage was the major finding. Due to the large
hematoma, no clear anatomical association to retroperi-
toneal organs could be established. Although acute bleed-
ing may sometimes be associated with this syndrome, in
this case, it was obvious that microthrombotic events in
the adrenal veins led to secondary hemorrhage, because
coagulation tests were never critically changed (Tab. 1).
Additionally, in the ultrasounds during the first week, the
left adrenal gland was slightly enlarged. This was an indi-
rect sign of thrombosis, which proceeded the hemorrhag-
ing 10 days later. In most reported cases, adrenal failure
has been linked to thrombotic complications of veins
leading to bilateral hemorrhage [4,6,7]. There are five
other reported cases of antiphospholipid syndrome and
adrenal failure in childhood [6,7,9-11]. However, the
clinical presentation is very variable (see Tab. 2- see Addi-
tional file 4) and gastrointestinal symptoms are not
always present.
The acute adrenal failure 10 days after admission, docu-
mented by the novel hemorrhage of the left adrenal gland
in the second CT scan, was followed by acute
hyponatremia caused by bilateral adrenal insufficiency.
Infarction or hemorrhage of the adrenal is a rare but
known complication of the antiphospholipid syndrome.
Signs of adrenal insufficiency appear when more than
90% of the adrenal cortex is destroyed. The possibility of
infectious or autoimmune adrenalitis, by far the most
common cause of adrenal insufficiency, was excluded
from consideration.
In our patient, the onset of organ insufficiency occured
very rapidly as cortisol and serum sodium were still nor-
mal six and two days before, respectively. Thus, the failure
of the complete adrenal function has to be attributed to
the second hemorrhage. In addition, acute hyponatremia
was accompanied by hemolytic anemia and elevated
transaminases. Recent studies suggest that these symp-
toms are autoimmune mediated, however, the pathogenic
mechanism is not well understood [2-4]. One different
hypothesis is due to the unique nature of the vascular
anatomy of the adrenal glands since they are rich with
arteial supply (3 arteries with up to 60 branches) but lim-
ited with venous drainage by a single vein. This however
may predispose thrombotic events.
Another complication in our patient was the development
of renal symptoms combined with hematuria and pro-
teinuria. Although renal function and blood pressure was
appropriate, β-2-microglobulin, a marker for tubular
injury, increased during the phase of hematuria (Table 1).Page 3 of 4
(page number not for citation purposes)
Thrombosis Journal 2005, 3:6 http://www.thrombosisjournal.com/content/3/1/6Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
In a recent study Nochy et al. reported 16 patients with
APS. All of them had biopsy proven vascular nephropathy
caused by small vessel vaso-occlusive lesions [8]. There-
fore, it is possible that involvement of the small renal ves-
sels also played a role in our patient.
This case demonstrates that APS in childhood may present
with a diverse and severe set of symptoms. Adrenal hem-
orrhage due to thrombosis should be considered as a
manifestation of the antiphospholipid syndrome. These
patients must be closely monitored because consecutive
thrombosis with secondary hemorrhage may rapidly
cause adrenal insufficiency.
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Figure 1: scanned ultrasound photography




Figure 2: scanned ultrasound photography




Figure 3: scanned photography of computer tomography
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